Showing results (71-80 of 302) with videos related to

Sort By:
Pageof 31
European Journal of Cancer (Oxford, England : 1990)|March 14, 2024
Anti-PD-(L)1 plus BRAF/MEK inhibitors (triplet therapy) after failure of immune checkpoint inhibition and targeted therapy in patients with advanced melanomaLea Jessica Albrecht, Florentia Dimitriou, Piyush Grover, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2023
Practical guidelines for the management of adverse events of the T cell engager bispecific tebentafuspJessica C Hassel, Carola Berking, Andrea Forschner, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 6, 2017
Radiosensibilisierung durch BRAF InhibitorenSophia Boyoung Strobel, Sylvie Pätzold, Lisa Zimmer, et al.
Plos One|May 3, 2013
Prognostic factors of melanoma patients with satellite or in-transit metastasis at the time of stage III diagnosisBenjamin Weide, Christine Faller, Petra Büttner, et al.
Melanoma Research|June 11, 2015
Complete remission of metastatic melanoma upon BRAF inhibitor treatment - what happens after discontinuation?Henrike Tolk, Imke Satzger, Peter Mohr, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 31, 2017
Radiosensitization by BRAF inhibitorsSophia Boyoung Strobel, Sylvie Pätzold, Lisa Zimmer, et al.
International Journal of Cancer|November 11, 2025
Characterization of long-term survivors with liver metastases from uveal melanoma diagnosed between 2005 and 2021Jona Laukhuf, Lisa Wiens, Gerd Grözinger, et al.
Pageof 31